BACKGROUND: Two genetic variants in apolipoprotein L1 (APOL1) are associated with increased risk of focal segmental glomerulosclerosis as well as other glomerular phenotypes. These risk variants are common in individuals of African ancestry but absent in other racial groups. Yet, the majority of individuals with two APOL1 risk alleles [high-risk (HR) genotype] do not have renal disease. It is critical to identify environmental and secondary genetic influences that, when combined with these alleles, lead to kidney disease. In a recent study of black children with glomerular disease enrolled in the Nephrotic Syndrome Study Network (NEPTUNE) and Chronic Kidney Disease in Children Study (n = 104), we found that subjects with an HR genotype had a 4.6-fold increase in the odds of preterm birth as compared to those with a low risk (LR) genotype [odds ratio 4.6 (CI 1.4-15.5)]. There are known racial disparities in preterm birth, which itself is a known risk factor for chronic kidney disease and focal segmental glomerulosclerosis. Thus, we questioned whether an HR APOL1 genotype is associated with prematurity in the general African American population. METHODS: We analyzed two publically available genetic datasets of preterm birth in African Americans, including 867 infants and 519 mothers from the Gene Environment Association Studies (GENEVA) study of preterm delivery and 960 mothers from the Boston Medical Center genome-wide association study of preterm birth. We performed multivariable analyses testing for association between HR APOL1 and birth outcomes. RESULTS: In both studies, there was no association between HR APOL1 in mothers and prematurity, gestational age or birthweight. Additionally, in the GENEVA study, we saw no association between infant HR APOL1 and prematurity, gestational age or birthweight. CONCLUSION: From these data, we conclude that the previously observed association between HR APOL1 and prematurity is specific to those with glomerular disease, suggesting prematurity may act as an additional risk factor in APOL1-associated renal disease.
BACKGROUND: Two genetic variants in apolipoprotein L1 (APOL1) are associated with increased risk of focal segmental glomerulosclerosis as well as other glomerular phenotypes. These risk variants are common in individuals of African ancestry but absent in other racial groups. Yet, the majority of individuals with two APOL1 risk alleles [high-risk (HR) genotype] do not have renal disease. It is critical to identify environmental and secondary genetic influences that, when combined with these alleles, lead to kidney disease. In a recent study of black children with glomerular disease enrolled in the Nephrotic Syndrome Study Network (NEPTUNE) and Chronic Kidney Disease in Children Study (n = 104), we found that subjects with an HR genotype had a 4.6-fold increase in the odds of preterm birth as compared to those with a low risk (LR) genotype [odds ratio 4.6 (CI 1.4-15.5)]. There are known racial disparities in preterm birth, which itself is a known risk factor for chronic kidney disease and focal segmental glomerulosclerosis. Thus, we questioned whether an HR APOL1 genotype is associated with prematurity in the general African American population. METHODS: We analyzed two publically available genetic datasets of preterm birth in African Americans, including 867 infants and 519 mothers from the Gene Environment Association Studies (GENEVA) study of preterm delivery and 960 mothers from the Boston Medical Center genome-wide association study of preterm birth. We performed multivariable analyses testing for association between HR APOL1 and birth outcomes. RESULTS: In both studies, there was no association between HR APOL1 in mothers and prematurity, gestational age or birthweight. Additionally, in the GENEVA study, we saw no association between infant HR APOL1 and prematurity, gestational age or birthweight. CONCLUSION: From these data, we conclude that the previously observed association between HR APOL1 and prematurity is specific to those with glomerular disease, suggesting prematurity may act as an additional risk factor in APOL1-associated renal disease.
Authors: David J Friedman; Julia Kozlitina; Giulio Genovese; Prachi Jog; Martin R Pollak Journal: J Am Soc Nephrol Date: 2011-10-13 Impact factor: 10.121
Authors: Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler Journal: J Am Soc Nephrol Date: 2011-10-13 Impact factor: 10.121
Authors: Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu M Madhavan; Martha Konieczkowski; Paul E Drawz; David B Thomas; Laura Barisoni; John R Sedor; John F O'Toole Journal: J Am Soc Nephrol Date: 2016-03-29 Impact factor: 10.121
Authors: Sangeeta Hingorani; Robert Schmicker; Kaashif A Ahmad; Ivan D Frantz; Dennis E Mayock; Edmund F La Gamma; Mariana Baserga; Janine Y Khan; Maureen M Gilmore; Tonya Robinson; Patrick Brophy; Patrick J Heagerty; Sandra E Juul; Stuart Goldstein; David Askenazi Journal: Clin J Am Soc Nephrol Date: 2022-07-19 Impact factor: 10.614
Authors: Xiumei Hong; Avi Z Rosenberg; Boyang Zhang; Elizabeth Binns-Roemer; Victor David; Yiming Lv; Rebecca C Hjorten; Kimberly J Reidy; Teresa K Chen; Guoying Wang; Yuelong Ji; Claire L Simpson; Robert L Davis; Jeffrey B Kopp; Xiaobin Wang; Cheryl A Winkler Journal: Am J Kidney Dis Date: 2020-12-22 Impact factor: 11.072
Authors: Anna K Miller; Timur Azhibekov; John F O'Toole; John R Sedor; Scott M Williams; Raymond W Redline; Leslie A Bruggeman Journal: BMC Med Genet Date: 2020-05-20 Impact factor: 2.103
Authors: Keia R Sanderson; Emily Chang; Erica Bjornstad; Susan L Hogan; Yichun Hu; David Askenazi; Rebecca C Fry; T Michael O'Shea Journal: Front Pediatr Date: 2020-05-12 Impact factor: 3.418
Authors: Kimberly J Reidy; Rebecca C Hjorten; Claire L Simpson; Avi Z Rosenberg; Stacy D Rosenblum; Csaba P Kovesdy; Frances A Tylavsky; Joseph Myrie; Bianca L Ruiz; Soulin Haque; Khyobeni Mozhui; George W Nelson; Victor A David; Xiaoping Yang; Masako Suzuki; Jack Jacob; Sandra E Reznik; Frederick J Kaskel; Jeffrey B Kopp; Cheryl A Winkler; Robert L Davis Journal: Am J Hum Genet Date: 2018-08-30 Impact factor: 11.025
Authors: Debbie S Gipson; David T Selewski; Susan F Massengill; Mary Margaret Modes; Hailey Desmond; Lauren Lee; Elaine Kamil; Matthew R Elliott; Sharon G Adler; Gia Oh; Richard A Lafayette; Patrick E Gipson; Aditi Sinha; Arvind Bagga; Anne Pesenson; Cheryl Courtlandt; Cathie Spino; Richard Eikstadt; Renée Pitter; Samara Attalla; Anne Waldo; Richard Winneker; Noelle E Carlozzi; Jonathan P Troost; Irving Smokler; Mark Stone Journal: Kidney Int Rep Date: 2017-11-28